Lanean...
Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions
Gastro-esophageal adenocarcinomas (GEA) represent a severe global health burden and despite improvements in the multimodality treatment of these malignancies the prognosis of patients remains poor. HER2 overexpression/amplification has been the first predictive biomarker approved in clinical practic...
Gorde:
| Argitaratua izan da: | Cancer Cell Int |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6042434/ https://ncbi.nlm.nih.gov/pubmed/30008616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-018-0594-z |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|